OTC: GBUX

GIVBUX, INC.

CIK 0001169138 · SIC 7389 · Miscellaneous Business Services NEC

Micro Revenue $289K Assets $100K as of Sep 10, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.

10-Q Filed Sep 9, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jun 5, 2026 · Period ending May 29, 2026

Summary not yet generated.

Partner

Trade GBUX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed May 14, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Apr 15, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

S-1/A Filed Mar 18, 2026

Summary not yet generated.

10-Q Filed Nov 19, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

S-1/A Filed Oct 7, 2025

Summary not yet generated.

10-K/A Filed Sep 22, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

S-1/A Filed Jul 23, 2025

Summary not yet generated.

S-1 Filed Jul 15, 2025

Summary not yet generated.

8-K Filed Jun 18, 2025 · Period ending May 9, 2025

Summary not yet generated.

8-K Filed Jun 9, 2025 · Period ending May 13, 2025

Summary not yet generated.

10-K Filed Apr 15, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

10-Q/A Filed Mar 27, 2025 · Period ending Sep 30, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Sep 9, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statement of Operations (Unaudited)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Revenue 34,264 55,803 90,170 121,826
Cost of revenue 27,413 39,434 57,339 94,584
Gross profit 6,851 16,369 32,831 27,242
Operating expenses
General and administrative 110,412 303,115 371,603 482,641
Sales and marketing 5,949 68,492 6,049 68,577
Stock based-compensation -commitment fees - - 22,664 -
Professional fees 199,863 182,343 384,485 197,125
Total operating expenses 316,224 553,950 784,801 748,343
Loss from operations (309,373) (537,581) (751,970) (721,101)
Other income (expense)
Interest expense (281,478) (269,382) (441,437) (380,832)
Change in fair value of derivative liabilities 130,400 (5,320,673) 469,365 (5,552,522)
Loss on conversion convertible notes (90,824) - (88,609) -
Gain on extinguishment of convertible note 534 - 54,834 -
Gain on modification of convertible note 2,647 - 2,647 -
Gain on settlement of liabilities - 22,805 22,805
Total other expense (238,721) (5,567,250) (3,200) (5,910,549)
Loss before income taxes (548,094) (6,104,831) (755,170) (6,631,650)
Provision for income taxes - - - -
Net loss (548,094) (6,104,831) (755,170) (6,631,650)
Basic and diluted loss per Common Share (0.00) (0.06) (0.01) (0.07)
Basic and diluted weighted average number of common shares outstanding 141,322,233 94,819,184 121,511,509 94,756,839

Consolidated Balance sheets (Unaudited)

Description June 30, 2026 December 31, 2025
Assets
Current assets
Cash 17,976 126,807
Prepaid expenses 20,000 45,250
Other receivable 380 280
Deferred offering costs 61,600 61,600
Total current assets 99,956 233,937
Property and equipment, net - 8,748
Total Assets 99,956 242,685
Liabilities and Stockholders' Deficit
Current Liabilities
Accounts payable and accrued liabilities 1,424,122 1,172,757
Advances for convertible notes to be issued 45,000 -
Due to related party 3,275 3,275
Notes payable related parties 766,272 807,740
Loans payable, net discount of $0 434,500 434,500
Convertible notes, net discount of $253,000 and $121,464 1,526,661 1,613,580
Derivative liabilities 973,428 1,156,230
Total Current Liabilities 5,173,258 5,188,082
Total Liabilities 5,173,258 5,188,082
Stockholders' Deficit
Preferred stock: 10,000,000 authorized; $0.001 par value 1,000,000 and 0 shares of Series C Preferred Stock issued and outstanding, respectively 1,000 -
Common stock: 3,490,000,000 authorized; $0.001 par value 174,150,989 and 99,061,523 shares issued and outstanding, respectively 174,151 99,062
Additional paid in capital 29,620,211 29,085,106
Common stock to be issued, 15,046,667 shares 86,071 70,000
Collateral stock, at par value: 2,775,000 shares (2,775) (2,775)
Accumulated deficit (34,951,960) (34,196,790)
Total Stockholders' Deficit (5,073,302) (4,945,397)
Total Liabilities and Stockholders' Deficit 99,956 242,685

Consolidated Statement of Cash Flows (Unaudited)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss (755,170) (6,631,650)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation-services - 177,401
Stock-based compensation-commitment fees 22,664 -
Restricted stock based compensation 258,348 -
Amortization of debt discount 343,678 300,252
Depreciation 8,748 4,373
Change in fair value of derivative liabilities (469,365) 5,552,522
Gain on extinguishment of convertible note (54,834) -
Gain on modification of convertible note (2,647) -
Gain on settlement of liability - 22,805
Loss on conversion of convertible note 88,609 -
Prepaid expenses 25,250 (40,917)
Other receivable (100) -
Accounts payable and accrued liabilities 308,652 5,055
Accrued interest-related parties 12,906 12,922
Net Cash used in Operating Activities (213,261) (597,237)
CASH FLOWS FROM INVESTING ACTIVITIES:
Improvement leased property - (26,241)
Net Cash used in Investing Activities - (26,241)
CASH FLOWS FROM FINANCING ACTIVITIES:
Advances for convertible notes to be issued 45,000 15,000
Bank overdraft 2,505 -
Deferred offering cost - (55,000)
Proceeds from loans payable - 35,000
Proceeds from convertible notes 140,300 734,559
Repayment of convertible notes (30,000) -
Repayment of loans payable - (36,000)
Proceeds from related parties 32,785 7,250
Repayment loan of related parties (86,160) (77,548)
Net Cash provided by Financing Activities 104,430 623,261
Net change in cash (108,831) (217)
Cash, beginning of period 126,807 18,374
Cash, end of period 17,976 18,157
Supplemental cash flow information
Cash paid for interest - -
Cash paid for taxes - -
Non-cash Investing and Financing transactions:
Common stock issued for compensation -management 565 -
Dividend in form of warrants - 23,147,870
Common stock issued for compensation- services - 177,401
Common stock issued for convertible note-commitment shares 22,664 623,877
Common stock issued for conversion convertible notes 329,182 -
Derivative liabilities recognized as debt discount 427,749 429,972
Issuance convertible note in exchange with another convertible note 63,199 -
Derivatives liabilities recognized as debt discount -warrant - 510,000
Common stock commitment payable recognized as debt discount 16,071 -
Issuance Series C Preferred Stock in exchange with due to related party 1,000 -

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗